drugset / Trial / NCT06425341
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
RandomizedParallel-groupOpen-labelTreatment
Summary
A multicenter, randomized, open, parallel-designed Phase II study to evaluate the efficacy and safety of HRS-5635 injection alone or in combination with other agents in patients treated for chronic hepatitis B.
Timeline
- Start
- 2024-06-06
- Primary completion
- 2026-08-30
- Completion
- 2027-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5635 | Unknown | — | Subcutaneous |
| Subject | Peginterferon alfa-2a | Protein / enzyme biologic | — | Subcutaneous |